V012-6991 Screening compound: 3-(3,5-difluorobenzamido)-N-[1-(3-phenylpropanoyl)piperidin-4-yl]pyrazine-2-carboxamide

V012-6991 Screening compound: 3-(3,5-difluorobenzamido)-N-[1-(3-phenylpropanoyl)piperidin-4-yl]pyrazine-2-carboxamide
V012-6991 Screening compound: 3-(3,5-difluorobenzamido)-N-[1-(3-phenylpropanoyl)piperidin-4-yl]pyrazine-2-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V012-6991
3-(3,5-difluorobenzamido)-N-[1-(3-phenylpropanoyl)piperidin-4-yl]pyrazine-2-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V012-6991

Molecular Formula

C26H25F2N5O3 (C26 H25 F2 N5 O3)

Compound Name

3-(3,5-difluorobenzamido)-N-[1-(3-phenylpropanoyl)piperidin-4-yl]pyrazine-2-carboxamide

IUPAC name

3-(35-difluorobenzamido)-N-[1-(3-phenylpropanoyl)piperidin-4-yl]pyrazine-2-carboxamide

SMILES

O=C(CCc1ccccc1)N(CC1)CCC1NC(c1nccnc1NC(c1cc(F)cc(F)c1)=O)=O

InChI

InChI=1S/C26H25F2N5O3/c27-19-14-18(15-20(28)16-19)25(35)32-24-23(29-10-11-30-24)26(36)31-21-8-12-33(13-9-21)22(34)7-6-17-4-2-1-3-5-17/h1-5,10-11,14-16,21H,6-9,12-13H2,(H,31,36)(H,30,32,35)

InChI Key

JSRAEXSHQXLJHB-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19906916

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

493.51

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.967

Distribution Coefficient, logD

0.286

Water Solubility, LogSw

-3.43

Polar Surface Area

82.903

Acid Dissociation Constant (pKa)

4.72

Base Dissociation Constant (pKb)

-0.13

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

26.90

V012-6991 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

Chelators targeting matrix metalloproteinases library (8930 compounds)

Type II Kinase Inhibitors Library (6956 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Cardiovascular
  • Digestive system
  • Hemic and lymphatic
  • Endocrine
Targets:
  • Proteases
  • Kinases

References: we are preparing a list of scientific research reports with V012-6991 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V012-6991?
Check Price and Availability of V012-6991, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V012-6991 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V012-6991
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V012-6991
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V012-6991 available by request